improved progression-free survival with iressa as adjuvant therapy
Published 7 years ago • 542 plays • Length 7:53Download video MP4
Download video MP3
Similar videos
-
1:59:57
grace - global resource for advancing cancer education live stream
-
3:25
is progression-free survival meaningful?
-
6:56
2020 ttf rare mutations qa panel why mutations have different progression-free survival averages
-
7:59
dacomitinib beats iressa as first line treatment for egfr mutation-positive nsclc
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
3:25
are there significant differences among the 1st and 2nd generation egfr tkis?
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
7:13
continuing immunotherapy beyond progression
-
2:44
grace targeted therapies lung cancer 2021 -progression on tagrisso, amivantamab or better treatment?
-
0:54
gracecastuc-072_lung_how to manage acqd. resistance with single lesion or more diffuse progression?
-
2:55
adjuvant therapy for melanoma - 2022 program: melanoma video library
-
6:26
the adaura trial: the effect on egfr treatment
-
6:14
key points from the adaura trial: osimertinib
-
3:14
stereotactic body radiotherapy (sbrt) for oligoprogressive nsclc - onctalk lung 2023
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum
-
3:21
when should progression lead to treatment changes? - 2022 program: targeted therapies forum
-
25:10
life after 1st line targeted therapy: what next?
-
9:36
gracecast-021_lung-cancer_stage iiia management options